» Articles » PMID: 30279970

Cancer Stem Cells in Progression of Colorectal Cancer

Overview
Journal Oncotarget
Specialty Oncology
Date 2018 Oct 4
PMID 30279970
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer is one of the most common cancers worldwide with high mortality. Distant metastasis and relapse are major causes of patient death. Cancer stem cells (CSCs) play a critical role in the metastasis and relapse of colorectal cancer. CSCs are a subpopulation of cancer cells with unique properties of self-renewal, infinite division and multi-directional differentiation potential. Colorectal CSCs are defined with a group of cell surface markers, such as CD44, CD133, CD24, EpCAM, LGR5 and ALDH. They are highly tumorigenic, chemoresistant and radioresistant and thus are critical in the metastasis and recurrence of colorectal cancer and disease-free survival. This review article updates the colorectal CSCs with a focus on their role in tumor initiation, progression, drug resistance and tumor relapse.

Citing Articles

Critical roles of miR-21 in promotions angiogenesis: friend or foe?.

Saadh M, Jasim N, Ahmed M, Ballal S, Kumar A, Atteri S Clin Exp Med. 2025; 25(1):66.

PMID: 39998742 PMC: 11861128. DOI: 10.1007/s10238-025-01600-7.


Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer.

Mzoughi S, Schwarz M, Wang X, Demircioglu D, Ulukaya G, Mohammed K Nat Genet. 2025; 57(2):402-412.

PMID: 39930084 PMC: 11821538. DOI: 10.1038/s41588-024-02058-1.


Oxidative Phosphorylation as a Predictive Biomarker of Oxaliplatin Response in Colorectal Cancer.

Martinez-Bernabe T, Pons D, Oliver J, Sastre-Serra J Biomolecules. 2024; 14(11).

PMID: 39595536 PMC: 11591675. DOI: 10.3390/biom14111359.


The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies.

Wang H, Tang R, Jiang L, Jia Y Front Pharmacol. 2024; 15:1494802.

PMID: 39555098 PMC: 11565213. DOI: 10.3389/fphar.2024.1494802.


Veratridine, a plant-derived alkaloid, suppresses the hyperactive Rictor-mTORC2 pathway: a new targeted therapy for primary and metastatic colorectal cancer.

Eikanger M, Sane S, Schraufnagel K, Slunecka J, Potts R, Freeling J Res Sq. 2024; .

PMID: 39502780 PMC: 11537347. DOI: 10.21203/rs.3.rs-5199838/v1.


References
1.
Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T . Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005; 5(9):744-9. DOI: 10.1038/nrc1694. View

2.
Uchida H, Yamazaki K, Fukuma M, Yamada T, Hayashida T, Hasegawa H . Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Sci. 2010; 101(7):1731-7. PMC: 11159016. DOI: 10.1111/j.1349-7006.2010.01571.x. View

3.
Basu S, Haase G, Ben-Zeev A . Wnt signaling in cancer stem cells and colon cancer metastasis. F1000Res. 2016; 5. PMC: 4841194. DOI: 10.12688/f1000research.7579.1. View

4.
Li F, Zhou K, Gao L, Zhang B, Li W, Yan W . Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistance. Oncol Lett. 2016; 12(5):3059-3065. PMC: 5103903. DOI: 10.3892/ol.2016.5124. View

5.
Shibue T, Weinberg R . EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017; 14(10):611-629. PMC: 5720366. DOI: 10.1038/nrclinonc.2017.44. View